ArticleInternational journal of molecular sciences2021
Interest of Homodialkyl Neamine Derivatives against Resistant
Jitendriya Swain, Clément Dezanet, Hussein Chalhoub, Marie Auquière, Julie Kempf, Jean-Luc Décout, Marie-Paule Mingeot-Leclercq
Open access · goldAbstract read
In one paragraphArticle in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 62% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors at 2 institutions in 2 countries.
Jitendriya SwainUniversité Catholique de Louvain, Louvain Drug Research Institute, Pharmacologie Cellulaire et Moléculaire, Avenue E. Mounier 73, UCL B1.73.05, 1200 Brussels, Belgium.
Clément DezanetUniversité Grenoble Alpes, CNRS, Département de Pharmacochimie Moléculaire, Rue de la Chimie, F-38041 Grenoble, France.
Hussein ChalhoubUniversité Catholique de Louvain, Louvain Drug Research Institute, Pharmacologie Cellulaire et Moléculaire, Avenue E. Mounier 73, UCL B1.73.05, 1200 Brussels, Belgium.
Marie AuquièreUniversité Catholique de Louvain, Louvain Drug Research Institute, Pharmacologie Cellulaire et Moléculaire, Avenue E. Mounier 73, UCL B1.73.05, 1200 Brussels, Belgium.
Julie KempfUniversité Grenoble Alpes, CNRS, Département de Pharmacochimie Moléculaire, Rue de la Chimie, F-38041 Grenoble, France.
Jean-Luc DécoutUniversité Grenoble Alpes, CNRS, Département de Pharmacochimie Moléculaire, Rue de la Chimie, F-38041 Grenoble, France.ORCID 0000-0001-7058-1304 Marie-Paule Mingeot-LeclercqUniversité Catholique de Louvain, Louvain Drug Research Institute, Pharmacologie Cellulaire et Moléculaire, Avenue E. Mounier 73, UCL B1.73.05, 1200 Brussels, Belgium.
UCLouvain · BECentre National de la Recherche Scientifique · FR
Funding
Fondation pour la Recherche Médicale, SATT Linksium Grenoble Alpes and Labex Arcane; CBH-EUR-GS DBF20161136768 ANR-17-EURE-0003Fonds de la Recherche Scientifique Medicale T.1003.14 and J.0205.16
6 · The paper itselfAbstract
Development of novel therapeutics to treat antibiotic-resistant infections, especially those caused by ESKAPE pathogens, is urgent. One of the most critical pathogens is
Indexed as
Allyl CompoundsAnti-Bacterial AgentsCell MembraneCell Membrane PermeabilityDrug Resistance, BacterialEscherichia coliFramycetinGram-Negative BacteriaLipopolysaccharidesMicrobial Sensitivity TestsPseudomonas aeruginosaAllyl CompoundsAnti-Bacterial AgentsFramycetinLipopolysaccharidesneamineamphiphilic aminoglycosidesantibioticsbacterial lipid membraneESBLlipopolysaccharidesP. aeruginosa
Identifiers
PMID34445410
PMCPMC8396045
OpenAlexW3193725171
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390